Skip to main content

Table 2 Medication

From: Disease management programs for patients with type 2 diabetes mellitus in Germany: a longitudinal population-based descriptive study

 

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

Antihyperglycemic medication

 n

206,015

246,453

270,251

309,867

344,343

367,046

390,126

406,919

421,065

422,019

423,640

425,342

 %

75.7

76.4

76.4

76.4

77.6

77.2

77.1

76.4

75.5

74.7

73.8

73.3

Metformin

 n

110,237

139,903

160,445

192,346

223,018

245,607

269,810

288,871

303,841

307,339

310,177

314,075

 %

40.5

43.4

45.3

47.4

50.2

51.7

53.3

54.3

54.5

54.4

54.0

54.1

Insulin

 n

67,491

79,835

88,270

100,335

108,872

113,476

117,963

121,185

125,045

126,496

128,680

131,760

 %

24.8

24.8

24.9

24.7

24.5

23.9

23.3

22.8

22.4

22.4

22.4

22.7

Of which

 Monotherapy

  n

37,378

42,517

45,574

50,090

51,680

51,583

51,011

50,229

49,289

47,134

45,397

44,347

  %

55.4

53.3

51.6

49.9

47.5

45.5

43.2

41.4

39.4

37.3

35.3

33.7

 With metformin

  n

19,182

24,691

29,586

35,946

41,452

45,734

50,160

53,992

58,085

60,871

63,473

66,900

  %

28.4

30.9

33.5

35.8

38.1

40.3

42.5

44.6

46.5

48.1

49.3

50.8

  1. DMP diabetes mellitus Typ 2: 2004–2015